1. Home
  2. CTSO vs NISN Comparison

CTSO vs NISN Comparison

Compare CTSO & NISN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • NISN
  • Stock Information
  • Founded
  • CTSO 1997
  • NISN 2005
  • Country
  • CTSO United States
  • NISN China
  • Employees
  • CTSO N/A
  • NISN N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • NISN Metal Fabrications
  • Sector
  • CTSO Health Care
  • NISN Industrials
  • Exchange
  • CTSO Nasdaq
  • NISN Nasdaq
  • Market Cap
  • CTSO 57.2M
  • NISN 46.0M
  • IPO Year
  • CTSO N/A
  • NISN 2016
  • Fundamental
  • Price
  • CTSO $0.98
  • NISN $7.98
  • Analyst Decision
  • CTSO Strong Buy
  • NISN
  • Analyst Count
  • CTSO 3
  • NISN 0
  • Target Price
  • CTSO $4.67
  • NISN N/A
  • AVG Volume (30 Days)
  • CTSO 147.2K
  • NISN 120.8K
  • Earning Date
  • CTSO 11-07-2024
  • NISN 10-15-2024
  • Dividend Yield
  • CTSO N/A
  • NISN N/A
  • EPS Growth
  • CTSO N/A
  • NISN 12.54
  • EPS
  • CTSO N/A
  • NISN 4.19
  • Revenue
  • CTSO $37,739,531.00
  • NISN $452,263,984.00
  • Revenue This Year
  • CTSO $13.09
  • NISN N/A
  • Revenue Next Year
  • CTSO $15.68
  • NISN N/A
  • P/E Ratio
  • CTSO N/A
  • NISN $2.05
  • Revenue Growth
  • CTSO 1.80
  • NISN 86.06
  • 52 Week Low
  • CTSO $0.70
  • NISN $2.50
  • 52 Week High
  • CTSO $2.15
  • NISN $22.55
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 44.01
  • NISN 36.75
  • Support Level
  • CTSO $0.71
  • NISN $9.55
  • Resistance Level
  • CTSO $0.99
  • NISN $11.31
  • Average True Range (ATR)
  • CTSO 0.09
  • NISN 1.18
  • MACD
  • CTSO 0.00
  • NISN 0.01
  • Stochastic Oscillator
  • CTSO 59.97
  • NISN 10.96

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales, Distributors/strategic partners, and Government segments. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About NISN NiSun International Enterprise Development Group Co. Ltd.

NiSun International Enterprise Development Group Co Ltd is a provider of supply chain solutions and integrated financial services. Nisun is dedicated to providing professional supply chain solutions to Chinese and foreign enterprises and financial institutions. Through its subsidiaries, it is engaged in delivering supply chain solutions, and supply chain trading services to its customers across different industries. The company also provides financial solutions to small and mid-sized enterprises within the supply chain ecosystem. Using its fintech platforms, it provides various financing options, including supply chain financing, trade financing, and receivables financing. Geographically, its operations are predominantly focused on markets within the People's Republic of China.

Share on Social Networks: